KPV dosage chart
This summary table compares available dose amounts and schedules by administration route.
| Route | Dose | Frequency & duration |
|---|---|---|
| Oral | 1–2 mg | 1-2 times daily · 4–8 wk |
| Topical | 10 mg per 30 mL serum (about 0.33 mg/mL) | Not established |
| Injectable | 1–2 mg | 1-2 times daily · 4–8 wk |
| Transdermal | 0.5 mL of 10 mg/mL donor solution (5 mg loaded) | Single laboratory exposure · 6-hour current application; 26-hour observation |
KPV dosage by administration route
KPV oral dosage
Reported oral protocols use 1–2 mg per administration, 1-2 times daily. The listed course is 4–8 wk. Another reported pattern lists 300–500 mcg once daily for 4–8 weeks for oral or subcutaneous administration. It differs from the milligram range above; a change of route does not justify substituting one amount for another.[1][2][16][17]
KPV is the three-amino-acid C-terminal fragment of alpha-MSH. Its proposed role concerns inflammatory signaling at gut and skin barriers.[1][2][3][4]
KPV topical dosage
A ready-to-use KPV cosmetic serum contains 10 mg per 30 mL, approximately 0.33 mg/mL. This concentration describes the specific external-use serum; the public directions do not quantify an amount per application, daily frequency or course length.[15]
KPV is the three-amino-acid C-terminal fragment of alpha-MSH. Its proposed role concerns inflammatory signaling at gut and skin barriers.[5][3][4][1]
KPV injectable dosage
Reported injectable protocols use 1–2 mg per administration, 1-2 times daily. The listed course is 4–8 wk. An alternative schedule uses 300–500 mcg once daily over 4–8 weeks for subcutaneous use. This is an alternative reported microgram pattern, separate from the 1–2 mg pattern above.[6][7][16][17]
KPV is the three-amino-acid C-terminal fragment of alpha-MSH. Its proposed role concerns inflammatory signaling at gut and skin barriers.[6][7][3][4][1]
KPV transdermal — ex vivo iontophoresis / microneedles dosage
An excised-human-skin experiment uses 0.5 mL of 10 mg/mL KPV in the donor chamber, totaling 5 mg loaded over 0.64 cm². The iontophoresis comparison applies current for 6 hours and measures permeation over 26 hours. These figures describe the laboratory reservoir and observation period, not an absorbed amount or a daily patch course.[8][18]
The microneedle and iontophoresis comparisons measure transport across excised skin. A reservoir concentration and skin-permeation rate are separate measurements, and neither supplies a human patch course.[8][3][4][1]
Frequency and timing
Morning or evening timing is common.[1]
KPV dosage calculator
Convert your chosen KPV amount into volume and U-100 syringe units. Adjust the inputs to match your vial and preparation.
KPV safety and side effects
Side effects and long-term safety
Oral use raises gastrointestinal-tolerance and disease-context questions; topical use raises local irritation and formulation questions. Route-specific absorption, degradation, tissue exposure and dose-response remain unresolved.[6][5][1][9][3]
Route-specific dosing limits
Pregnancy, pediatric use, active inflammatory bowel disease, complex wounds and injectable product quality require separate caution from ordinary oral or topical tolerability. Additional schedules attributed to Everything Peptide are reported patterns; citing research does not make these schedules clinically established or approved product instructions.[4][9][7][17]
Stacks that include KPV
Open a stack dosage guide for its component amounts, schedules and supporting information.
For a blend calculation, each component's amount and the final volume must be known. A total blend weight alone cannot tell you the dose of each component.
